Table 2 Meta-analyses included in review
Review (Reference number) | Number of trials | N of total sample | Sex (% males) | Mean Age | SD Age | Age Range (Years) | AMSTAR Score |
|---|---|---|---|---|---|---|---|
Koshman et al. [35] | 12 | 2060 | NR | NR | NR | 58-80 | 7 |
Clark et al. [25] | 14 | 4264 | NR | NR | NR | 57-75 | 8 |
Gohler et al. [32] | 36 | 8341 | 37-99% | NR | NR | 56-79 | 5 |
Jovicic et al. [24] | 6 | 857 | 53-76% | NR | NR | 56-76 | 7 |
Holland et al. [34] | 30 | NR | 27-99% | NR | NR | 56-80 | 4 |
Kim & Soeken [23] | 4 | NR | NR | NR | NR | NR to 64.0 to 81.6 | 6 |
Phillips et al. [31] | 6 | 949 | 58% | 73 | NR | 62-79 | 8 |
Roccaforte et al. [28] | 33 | 3817 | 42% | 73 | NR | NR | 8 |
Taylor et al. [27] | 16 | 1627 | 23-86% | NR | NR | 70-80 | 9 |
Whellan et al. [36] | 19 | 5752 | NR | NR | NR | 56-80 | 2 |
Gonseth et al. [37] | 54: 27 randomized and 27 non-randomized | 3160 | NR | Over 70 in most trials | NR | Not summarized | 9 |
Gwadry-Sridhar et al. [33] | 8 | 1239 | 37-58% | NR | NR | 71 -80.3 | 6 |
McAlister et al. [30] | 29 | 5039 | NR | NR | NR | 56-80 | 5 |
Phillips et al. [29] | 18 | 3304 | 62% | NR | NR | NR | 7 |
McAlister et al. [26] | 11 | 2067 | NR | NR | NR | 63-80 | 5 |